Robert Berman
Direttore/Membro del Consiglio presso SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II
Profilo
Robert Berman was the founder of Biohaven Pharmaceuticals, Inc., which was founded in 2013, where he held the title of Chief Medical Officer from 2013 to 2019.
Currently, he is an Independent Director at Social Capital Suvretta Holdings Corp.
II, where he started in 2022.
Dr. Berman received his undergraduate degree from Yale University and another undergraduate degree from Icahn School of Medicine at Mount Sinai in 1990.
Posizioni attive di Robert Berman
| Società | Posizione | Inizio |
|---|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Direttore/Membro del Consiglio | 29/06/2022 |
Precedenti posizioni note di Robert Berman
| Società | Posizione | Fine |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Fondatore | 01/01/2019 |
Formazione di Robert Berman
| Yale University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Finance |
| Aziende private | 1 |
|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
- Borsa valori
- Insiders
- Robert Berman
